6 completed, 1 terminated, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow immunological diagnostic method: new trials by email Literature Review of immunological diagnostic method trials Research Report on immunological diagnostic method
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia DNA analysis, gene rearrangement analysis, microarray analysis - Leukemia | Completed | Children's Oncology Group | 9 | 2011-02-01 | 2016-05-18 | |
| Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections cytomegalovirus IE-1-specific cytotoxic T lymphocytes, cytomegalovirus pp65-specific cytotoxic T lymphocytes, therapeutic allogeneic lymphocytes - Cancer | Phase 1 | Unknown | Milton S. Hershey Medical Center | 20 | 2008-08-01 | 2013-12-18 |
| Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases immunosuppressive therapy, immunological diagnostic method, allogeneic hematopoietic stem cell transplantation - Chronic Myeloproliferative Disorders, Graft Versus Host Disease | Terminated | City of Hope Medical Center | 60 | 2008-06-01 | 2011-03-07 | |
| GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer sargramostim, immunohistochemistry staining method, immunological diagnostic method - Prostate Cancer | Phase 1 | Completed | University of California, San Francisco | 24 | 2006-07-01 | 2014-06-25 |
| Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia flow cytometry, immunological diagnostic method, laboratory biomarker analysis - Leukemia | Completed | ECOG-ACRIN Cancer Research Group | 40 | 2006-03-28 | 2017-05-19 | |
| Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy proteomic profiling, immunological diagnostic method, laboratory biomarker analysis - Prostate Cancer | Completed | Wake Forest University Health Sciences | 60 | 2006-02-01 | 2017-01-19 | |
| Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants immunological diagnostic method, physiologic testing - Cancer | Completed | Wake Forest University Health Sciences | 54 | 2005-09-01 | 2017-05-30 | |
| Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery aerosol sargramostim, sargramostim, cisplatin - Metastatic Cancer, Sarcoma | Phase 2 | Completed | Mayo Clinic | 39 | 2001-08-01 | 2011-05-16 |
Congenital Abnormalities (4) · Burkitt Lymphoma (3) · Leukemia (3) · Leukemia, Lymphocytic, Chronic, B-Cell (3) · Leukemia, Myeloid, Acute (3) · Lymphoma, B-Cell, Marginal Zone (3) · Lymphoma, Follicular (3) · Lymphoma, Large B-Cell, Diffuse (3) · Lymphoma, Large-Cell, Immunoblastic (3) · Lymphoma, Mantle-Cell (3) · Lymphoma, Non-Hodgkin (3) · Lymphoma, T-Cell, Cutaneous (3) · Multiple Myeloma (3) · Mycosis Fungoides (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)
Wake Forest University Health Sciences (2) · Children's Oncology Group (1) · City of Hope Medical Center (1) · ECOG-ACRIN Cancer Research Group (1) · Mayo Clinic (1) · Milton S. Hershey Medical Center (1) · University of California, San Francisco (1)
United States (5)
David Senitzer, PhD (1) · Elisabeth Paietta, PhD (1) · Eric Guest, MD (1) · Frank M. Torti, MD, MPH (1) · Kenneth G. Lucas, MD (1) · Lawrence Fong, MD (1) · Scott Okuno, MD (1) · Zheng Cui, PhD (1)
P30CA012197 (1), P30CA015083 (1), P30CA033572 (1)